{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T00:01:20Z","timestamp":1774051280904,"version":"3.50.1"},"reference-count":117,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2019,1,13]],"date-time":"2019-01-13T00:00:00Z","timestamp":1547337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Research Center of Portuguese Oncology Institute of Porto","award":["CI-IPOP-FBGEBC-27"],"award-info":[{"award-number":["CI-IPOP-FBGEBC-27"]}]},{"name":"Research Center of Portuguese Oncology Institute of Porto","award":["PI 74-CI-IPOP-19-2016"],"award-info":[{"award-number":["PI 74-CI-IPOP-19-2016"]}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BD\/112673\/2015"],"award-info":[{"award-number":["SFRH\/BD\/112673\/2015"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BD\/132751\/2017"],"award-info":[{"award-number":["SFRH\/BD\/132751\/2017"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Bladder cancer is one of the most incident neoplasms worldwide, and its treatment remains a significant challenge, since the mechanisms underlying disease progression are still poorly understood. The epithelial to mesenchymal transition (EMT) has been proven to play an important role in the tumorigenic process, particularly in cancer cell invasiveness and metastatic potential. Several studies have reported the importance of epigenetic mechanisms and enzymes, which orchestrate them in several features of cancer cells and, specifically, in EMT. In this paper, we discuss the epigenetic enzymes, protein-coding and non-coding genes, and mechanisms altered in the EMT process occurring in bladder cancer cells, as well as its implications, which allows for improved understanding of bladder cancer biology and for the development of novel targeted therapies.<\/jats:p>","DOI":"10.3390\/ijms20020297","type":"journal-article","created":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T12:20:07Z","timestamp":1547468407000},"page":"297","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Epigenetic Mechanisms Influencing Epithelial to Mesenchymal Transition in Bladder Cancer"],"prefix":"10.3390","volume":"20","author":[{"given":"Sara","family":"Monteiro-Reis","sequence":"first","affiliation":[{"name":"Cancer Biology and Epigenetics Group, Research Center, Portuguese Oncology Institute of Porto (CI-IPOP), R. Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6829-1391","authenticated-orcid":false,"given":"Jo\u00e3o","family":"Lobo","sequence":"additional","affiliation":[{"name":"Cancer Biology and Epigenetics Group, Research Center, Portuguese Oncology Institute of Porto (CI-IPOP), R. Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072 Porto, Portugal"},{"name":"Department of Pathology, Portuguese Oncology Institute of Porto (IPOP), R. Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072 Porto, Portugal"},{"name":"Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar, University of Porto (ICBAS-UP), Rua Jorge Viterbo Ferreira 228, 4050-513 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3171-4666","authenticated-orcid":false,"given":"Rui","family":"Henrique","sequence":"additional","affiliation":[{"name":"Cancer Biology and Epigenetics Group, Research Center, Portuguese Oncology Institute of Porto (CI-IPOP), R. Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072 Porto, Portugal"},{"name":"Department of Pathology, Portuguese Oncology Institute of Porto (IPOP), R. Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072 Porto, Portugal"},{"name":"Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar, University of Porto (ICBAS-UP), Rua Jorge Viterbo Ferreira 228, 4050-513 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4186-5345","authenticated-orcid":false,"given":"Carmen","family":"Jer\u00f3nimo","sequence":"additional","affiliation":[{"name":"Cancer Biology and Epigenetics Group, Research Center, Portuguese Oncology Institute of Porto (CI-IPOP), R. Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072 Porto, Portugal"},{"name":"Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar, University of Porto (ICBAS-UP), Rua Jorge Viterbo Ferreira 228, 4050-513 Porto, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2019,1,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/s41598-018-19199-z","article-title":"The global epidemiology of bladder cancer: A joinpoint regression analysis of its incidence and mortality trends and projection","volume":"8","author":"Wong","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_2","unstructured":"Ferlay, J., Ervik, M., Lam, F., Colombet, M., Mery, L., Pi\u00f1eros, M., Znaor, A., Soerjomataram, I., and Bray, F. (2018). Global Cancer Observatory: Cancer Tomorrow, WHO."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.eururo.2016.06.010","article-title":"Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends","volume":"71","author":"Antoni","year":"2017","journal-title":"Eur. Urol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/bju.13875","article-title":"Association of Human Development Index with global bladder, kidney, prostate and testis cancer incidence and mortality","volume":"120","author":"Greiman","year":"2017","journal-title":"BJU Int."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.eururo.2015.10.024","article-title":"Economic Burden of Bladder Cancer Across the European Union","volume":"69","author":"Leal","year":"2016","journal-title":"Eur. Urol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"17022","DOI":"10.1038\/nrdp.2017.22","article-title":"Bladder cancer","volume":"3","author":"Sanli","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Moch, H., Ulbright, T., Humphrey, P., and Reuter, V. (2016). WHO Classification of Tumours of the Urinary System and Male Genital Organs, IARC. [4th ed.].","DOI":"10.1016\/j.eururo.2016.02.029"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/nbt.1684","article-title":"Epigenetic modifications in pluripotent and differentiated cells","volume":"28","author":"Meissner","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/bdrc.20199","article-title":"Role of epigenetics in developmental biology and transgenerational inheritance","volume":"93","author":"Skinner","year":"2011","journal-title":"Birth Defects Res. C Embryo Today"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1242\/dev.050849","article-title":"Epigenetic reprogramming in mouse pre-implantation development and primordial germ cells","volume":"139","author":"Saitou","year":"2012","journal-title":"Development"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.gde.2017.03.015","article-title":"The promise of epigenetic therapy: Reprogramming the cancer epigenome","volume":"42","author":"Kelly","year":"2017","journal-title":"Curr. Opin. Genet. Dev."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Baylin, S.B., and Jones, P.A. (2016). Epigenetic Determinants of Cancer. Cold Spring Harb. Perspect. Biol., 8.","DOI":"10.1101\/cshperspect.a019505"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1056\/NEJMra072067","article-title":"Epigenetics in cancer","volume":"358","author":"Esteller","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/MOU.0000000000000078","article-title":"The burden of bladder cancer care: Direct and indirect costs","volume":"24","author":"Mossanen","year":"2014","journal-title":"Curr. Opin. Urol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s10147-016-1068-8","article-title":"Biomarkers for precision medicine in bladder cancer","volume":"22","author":"Kojima","year":"2017","journal-title":"Int. J. Clin. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2217\/epi.10.71","article-title":"Global epigenetic profiling in bladder cancer","volume":"3","author":"Dudziec","year":"2011","journal-title":"Epigenomics"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/978-1-4939-1804-1_10","article-title":"Epigenetics of urothelial carcinoma","volume":"1238","author":"Schulz","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1172\/JCI39104","article-title":"The basics of epithelial-mesenchymal transition","volume":"119","author":"Kalluri","year":"2009","journal-title":"J. Clin. Investig."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","article-title":"Emt: 2016","volume":"166","author":"Nieto","year":"2016","journal-title":"Cell"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1038\/nm.3336","article-title":"The epigenetics of epithelial-mesenchymal plasticity in cancer","volume":"19","author":"Tam","year":"2013","journal-title":"Nat. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrm1835","article-title":"Complex networks orchestrate epithelial-mesenchymal transitions","volume":"7","author":"Thiery","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrc3447","article-title":"Regulatory networks defining EMT during cancer initiation and progression","volume":"13","author":"Berx","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1007\/s00018-008-8281-1","article-title":"The cell-cell adhesion molecule E-cadherin","volume":"65","author":"Berx","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"7846","DOI":"10.1158\/0008-5472.CAN-08-1942","article-title":"A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition","volume":"68","author":"Bracken","year":"2008","journal-title":"Cancer Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"11271","DOI":"10.1158\/0008-5472.CAN-06-2044","article-title":"Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: Role of fibroblast growth factor receptor-2","volume":"66","author":"Chaffer","year":"2006","journal-title":"Cancer Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1167\/iovs.06-0639","article-title":"Transforming growth factor-beta1 represses E-cadherin production via slug expression in lens epithelial cells","volume":"48","author":"Choi","year":"2007","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: An open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"7274","DOI":"10.1038\/onc.2008.333","article-title":"Repression of E-cadherin by the polycomb group protein EZH2 in cancer","volume":"27","author":"Cao","year":"2008","journal-title":"Oncogene"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.ccr.2013.04.020","article-title":"Sox4 is a master regulator of epithelial-mesenchymal transition by controlling Ezh2 expression and epigenetic reprogramming","volume":"23","author":"Tiwari","year":"2013","journal-title":"Cancer Cell"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/bju.12702","article-title":"Enhancer of zeste homolog 2 (EZH2) promotes tumour cell migration and invasion via epigenetic repression of E-cadherin in renal cell carcinoma","volume":"117","author":"Liu","year":"2016","journal-title":"BJU Int."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1042\/BJ20111006","article-title":"MicroRNA-138 suppresses epithelial-mesenchymal transition in squamous cell carcinoma cell lines","volume":"440","author":"Liu","year":"2011","journal-title":"Biochem. J."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.canlet.2013.01.033","article-title":"Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression","volume":"333","author":"Luo","year":"2013","journal-title":"Cancer Lett."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.molcel.2011.06.020","article-title":"FGF-2 regulates cell proliferation, migration, and angiogenesis through an NDY1\/KDM2B-miR-101-EZH2 pathway","volume":"43","author":"Kottakis","year":"2011","journal-title":"Mol. Cell"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1158\/0008-5472.CAN-08-3114","article-title":"The putative tumor suppressor microRNA-101 modulates the cancer epigenome by repressing the polycomb group protein EZH2","volume":"69","author":"Friedman","year":"2009","journal-title":"Cancer Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1126\/science.1165395","article-title":"Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer","volume":"322","author":"Varambally","year":"2008","journal-title":"Science"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"McNiel, E.A., and Tsichlis, P.N. (2017). Analyses of publicly available genomics resources define FGF-2-expressing bladder carcinomas as EMT-prone, proliferative tumors with low mutation rates and high expression of CTLA-4, PD-1 and PD-L1. Signal Transduct. Target. Ther., 2.","DOI":"10.1038\/sigtrans.2016.45"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"5391","DOI":"10.1158\/1078-0432.CCR-14-2680","article-title":"Activation of EZH2 and SUZ12 Regulated by E2F1 Predicts the Disease Progression and Aggressive Characteristics of Bladder Cancer","volume":"21","author":"Lee","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1158\/1535-7163.MCT-15-0750","article-title":"BRD4 Regulates EZH2 Transcription through Upregulation of C-MYC and Represents a Novel Therapeutic Target in Bladder Cancer","volume":"15","author":"Wu","year":"2016","journal-title":"Mol. Cancer Ther."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1158\/1535-7163.MCT-17-0437","article-title":"Histone Methyltransferase EZH2: A Therapeutic Target for Ovarian Cancer","volume":"17","author":"Jones","year":"2018","journal-title":"Mol. Cancer Ther."},{"key":"ref_40","unstructured":"(2018, December 03). ORIOn-E: A Study Evaluating CPI-1205 in Patients with Advanced Solid Tumors, Available online: https:\/\/clinicaltrials.gov\/show\/NCT03525795."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1101\/gad.947102","article-title":"DNA methylation patterns and epigenetic memory","volume":"16","author":"Bird","year":"2002","journal-title":"Genes Dev."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1083\/jcb.200501038","article-title":"The epidermal barrier function is dependent on the serine protease CAP1\/Prss8","volume":"170","author":"Leyvraz","year":"2005","journal-title":"J. Cell Biol."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Chen, L.M., Verity, N.J., and Chai, K.X. (2009). Loss of prostasin (PRSS8) in human bladder transitional cell carcinoma cell lines is associated with epithelial-mesenchymal transition (EMT). BMC Cancer, 9.","DOI":"10.1186\/1471-2407-9-377"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1093\/hmg\/ddq128","article-title":"ELF5-enforced transcriptional networks define an epigenetically regulated trophoblast stem cell compartment in the human placenta","volume":"19","author":"Hemberger","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/ncb1786","article-title":"Epigenetic restriction of embryonic cell lineage fate by methylation of Elf5","volume":"10","author":"Ng","year":"2008","journal-title":"Nat. Cell Biol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Wu, B., Cao, X., Liang, X., Zhang, X., Zhang, W., Sun, G., and Wang, D. (2015). Epigenetic regulation of Elf5 is associated with epithelial-mesenchymal transition in urothelial cancer. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0117510"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1038\/onc.2016.165","article-title":"Overexpression of maelstrom promotes bladder urothelial carcinoma cell aggressiveness by epigenetically downregulating MTSS1 through DNMT3B","volume":"35","author":"Li","year":"2016","journal-title":"Oncogene"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"12870","DOI":"10.1038\/srep12870","article-title":"Growth differentiation factor-15: A p53- and demethylation-upregulating gene represses cell proliferation, invasion, and tumorigenesis in bladder carcinoma cells","volume":"5","author":"Tsui","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.juro.2013.08.087","article-title":"Epigenetic inactivation of KLF4 is associated with urothelial cancer progression and early recurrence","volume":"191","author":"Li","year":"2014","journal-title":"J. Urol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"102078","DOI":"10.18632\/oncotarget.22158","article-title":"CRISPR-ON-Mediated KLF4 overexpression inhibits the proliferation, migration and invasion of urothelial bladder cancer in vitro and in vivo","volume":"8","author":"Xu","year":"2017","journal-title":"Oncotarget"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"5842","DOI":"10.1158\/1078-0432.CCR-10-1312","article-title":"Three epigenetic biomarkers, GDF15, TMEFF2, and VIM, accurately predict bladder cancer from DNA-based analyses of urine samples","volume":"16","author":"Costa","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ejca.2013.08.025","article-title":"Accurate detection of upper tract urothelial carcinoma in tissue and urine by means of quantitative GDF15, TMEFF2 and VIM promoter methylation","volume":"50","author":"Leca","year":"2014","journal-title":"Eur. J. Cancer"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1158\/0008-5472.CAN-04-3619","article-title":"Drastic down-regulation of Kruppel-like factor 4 expression is critical in human gastric cancer development and progression","volume":"65","author":"Wei","year":"2005","journal-title":"Cancer Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.4161\/cbt.4.11.2090","article-title":"KLF4 and KLF5 regulate proliferation, apoptosis and invasion in esophageal cancer cells","volume":"4","author":"Yang","year":"2005","journal-title":"Cancer Biol. Ther."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"10182","DOI":"10.1158\/0008-5472.CAN-10-2414","article-title":"Prognostic value and function of KLF4 in prostate cancer: RNAa and vector-mediated overexpression identify KLF4 as an inhibitor of tumor cell growth and migration","volume":"70","author":"Wang","year":"2010","journal-title":"Cancer Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"5688","DOI":"10.1158\/1078-0432.CCR-09-0310","article-title":"Putative tumor-suppressive function of Kruppel-like factor 4 in primary lung carcinoma","volume":"15","author":"Hu","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"16009","DOI":"10.1038\/celldisc.2016.9","article-title":"A CRISPR-based approach for targeted DNA demethylation","volume":"2","author":"Xu","year":"2016","journal-title":"Cell Discov."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1093\/nar\/gkt1019","article-title":"Induced DNA demethylation by targeting Ten-Eleven Translocation 2 to the human ICAM-1 promoter","volume":"42","author":"Chen","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nsmb.2942","article-title":"Discovery and annotation of long noncoding RNAs","volume":"22","author":"Mattick","year":"2015","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10555-016-9628-y","article-title":"Deciphering the function of non-coding RNAs in prostate cancer","volume":"35","author":"Fromm","year":"2016","journal-title":"Cancer Metastasis Rev."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4161\/epi.27473","article-title":"Non-coding RNAs as direct and indirect modulators of epigenetic regulation","volume":"9","author":"Peschansky","year":"2014","journal-title":"Epigenetics"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41571-018-0035-x","article-title":"Clinical utility of circulating non-coding RNAs\u2014An update","volume":"15","author":"Anfossi","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nrg2504","article-title":"Small silencing RNAs: An expanding universe","volume":"10","author":"Ghildiyal","year":"2009","journal-title":"Nat. Rev. Genet."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"72758","DOI":"10.18632\/oncotarget.11805","article-title":"Computational identification of microRNAs associated to both epithelial to mesenchymal transition and NGAL\/MMP-9 pathways in bladder cancer","volume":"7","author":"Falzone","year":"2016","journal-title":"Oncotarget"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1158\/1078-0432.CCR-08-2245","article-title":"miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy","volume":"15","author":"Adam","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/1479-5876-11-276","article-title":"MicroRNA-124-3p inhibits cell migration and invasion in bladder cancer cells by targeting ROCK1","volume":"11","author":"Xu","year":"2013","journal-title":"J. Transl. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1074\/jbc.M112.408104","article-title":"The p63 protein isoform DeltaNp63alpha inhibits epithelial-mesenchymal transition in human bladder cancer cells: Role of MIR-205","volume":"288","author":"Tran","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Majid, S., Dar, A.A., Saini, S., Deng, G., Chang, I., Greene, K., Tanaka, Y., Dahiya, R., and Yamamura, S. (2013). MicroRNA-23b functions as a tumor suppressor by regulating Zeb1 in bladder cancer. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0067686"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s12967-014-0305-z","article-title":"miR-200c inhibits invasion, migration and proliferation of bladder cancer cells through down-regulation of BMI-1 and E2F3","volume":"12","author":"Liu","year":"2014","journal-title":"J. Transl. Med."},{"key":"ref_70","first-page":"7653","article-title":"miR-451 inhibits invasion and proliferation of bladder cancer by regulating EMT","volume":"7","author":"Zeng","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.3892\/ijo.2015.3117","article-title":"MicroRNA-24 upregulation inhibits proliferation, metastasis and induces apoptosis in bladder cancer cells by targeting CARMA3","volume":"47","author":"Zhang","year":"2015","journal-title":"Int. J. Oncol."},{"key":"ref_72","first-page":"935","article-title":"MicroRNA-34a regulates cell cycle by targeting CD44 in human bladder carcinoma cells","volume":"35","author":"Yu","year":"2015","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s13000-015-0372-3","article-title":"MiR-186 suppresses the growth and metastasis of bladder cancer by targeting NSBP1","volume":"10","author":"Yao","year":"2015","journal-title":"Diagn. Pathol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"42258","DOI":"10.18632\/oncotarget.5546","article-title":"A Polycomb-mir200 loop regulates clinical outcome in bladder cancer","volume":"6","author":"Duenas","year":"2015","journal-title":"Oncotarget"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.3892\/mmr.2014.2366","article-title":"Transforming growth factor\u03b21 induces epithelialmesenchymal transition and increased expression of matrix metalloproteinase16 via miR200b downregulation in bladder cancer cells","volume":"10","author":"Chen","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Liu, J., Cao, J., and Zhao, X. (2015). miR-221 facilitates the TGFbeta1-induced epithelial-mesenchymal transition in human bladder cancer cells by targeting STMN1. BMC Urol., 15.","DOI":"10.1186\/s12894-015-0028-3"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"24119","DOI":"10.18632\/oncotarget.4431","article-title":"DNMT1-dependent suppression of microRNA424 regulates tumor progression in human bladder cancer","volume":"6","author":"Wu","year":"2015","journal-title":"Oncotarget"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.3892\/ijmm.2015.2302","article-title":"miR4855p inhibits bladder cancer metastasis by targeting HMGA2","volume":"36","author":"Chen","year":"2015","journal-title":"Int. J. Mol. Med."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Wang, H., Ke, C., Ma, X., Zhao, Q., Yang, M., Zhang, W., and Wang, J. (2016). MicroRNA-92 promotes invasion and chemoresistance by targeting GSK3\u03b2 and activating Wnt signaling in bladder cancer cells. Tumour Biol.","DOI":"10.1007\/s13277-016-5460-9"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.3892\/or.2016.4940","article-title":"miR-92b targets DAB2IP to promote EMT in bladder cancer migration and invasion","volume":"36","author":"Huang","year":"2016","journal-title":"Oncol. Rep."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Zhou, M., Wang, S., Hu, L., Liu, F., Zhang, Q., and Zhang, D. (2016). miR-199a-5p suppresses human bladder cancer cell metastasis by targeting CCR7. BMC Urol., 16.","DOI":"10.1186\/s12894-016-0181-3"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"e2503","DOI":"10.1038\/cddis.2016.373","article-title":"miR-148a-3p represses proliferation and EMT by establishing regulatory circuits between ERBB3\/AKT2\/c-myc and DNMT1 in bladder cancer","volume":"7","author":"Wang","year":"2016","journal-title":"Cell Death Dis."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"26593","DOI":"10.18632\/oncotarget.8557","article-title":"MiR-429 reverses epithelial-mesenchymal transition by restoring E-cadherin expression in bladder cancer","volume":"7","author":"Wu","year":"2016","journal-title":"Oncotarget"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"e2088","DOI":"10.1038\/cddis.2015.274","article-title":"c-Met and CREB1 are involved in miR-433-mediated inhibition of the epithelial-mesenchymal transition in bladder cancer by regulating Akt\/GSK-3\u03b2\/Snail signaling","volume":"7","author":"Xu","year":"2016","journal-title":"Cell Death Dis."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.3727\/096504017X15041934685237","article-title":"MiR-203 Suppresses Bladder Cancer Cell Growth and Targets the Twist1","volume":"26","author":"Shen","year":"2017","journal-title":"Oncol. Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ijbiomac.2017.07.184","article-title":"Down-regulation of microRNA-224 -inhibites growth and epithelial-to-mesenchymal transition phenotype -via modulating SUFU expression in bladder cancer cells","volume":"106","author":"Miao","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"e3010","DOI":"10.1038\/cddis.2017.331","article-title":"MET\/SMAD3\/SNAIL circuit mediated by miR-323a-3p is involved in regulating epithelial-mesenchymal transition progression in bladder cancer","volume":"8","author":"Li","year":"2017","journal-title":"Cell Death Dis."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.3892\/mmr.2017.6805","article-title":"MicroRNA-497 upregulation inhibits cell invasion and metastasis in T24 and BIU-87 bladder cancer cells","volume":"16","author":"Wei","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"ref_89","first-page":"1213","article-title":"miR-613 inhibits bladder cancer proliferation and migration through targeting SphK1","volume":"9","author":"Yu","year":"2017","journal-title":"Am. J. Transl. Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41419-017-0206-1","article-title":"MiR-22 suppresses epithelial-mesenchymal transition in bladder cancer by inhibiting Snail and MAPK1\/Slug\/vimentin feedback loop","volume":"9","author":"Xu","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"e429","DOI":"10.1038\/emm.2017.239","article-title":"Effects of microRNA-135a on the epithelial-mesenchymal transition, migration and invasion of bladder cancer cells by targeting GSK3\u03b2 through the Wnt\/\u03b2-catenin signaling pathway","volume":"50","author":"Mao","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Huang, X., Zhu, H., Gao, Z., Li, J., Zhuang, J., Dong, Y., Shen, B., Li, M., Zhou, H., and Guo, H. (2018). Wnt7a activates canonical Wnt signaling, promotes bladder cancer cell invasion, and is suppressed by miR-370-3p. J. Biol. Chem.","DOI":"10.1074\/jbc.RA118.001689"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Liu, W., Qi, L., Lv, H., Zu, X., Chen, M., Wang, J., Liu, L., Zeng, F., and Li, Y. (2015). MiRNA-141 and miRNA-200b are closely related to invasive ability and considered as decision-making biomarkers for the extent of PLND during cystectomy. BMC Cancer, 15.","DOI":"10.1186\/s12885-015-1110-7"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1139\/bcb-2016-0232","article-title":"MiR-301b promotes the proliferation, mobility, and epithelial-to-mesenchymal transition of bladder cancer cells by targeting EGR1","volume":"95","author":"Yan","year":"2017","journal-title":"Biochem. Cell Biol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"6589","DOI":"10.1007\/s13277-015-4571-z","article-title":"Promoter-associated endogenous and exogenous small RNAs suppress human bladder cancer cell metastasis by activating p21 (CIP1\/WAF1) expression","volume":"37","author":"Wang","year":"2016","journal-title":"Tumour Biol."},{"key":"ref_96","first-page":"1923","article-title":"Tumor-suppressing effects of microRNA-612 in bladder cancer cells by targeting malic enzyme 1 expression","volume":"52","author":"Liu","year":"2018","journal-title":"Int. J. Oncol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.canlet.2017.06.027","article-title":"Circular RNA MYLK as a competing endogenous RNA promotes bladder cancer progression through modulating VEGFA\/VEGFR2 signaling pathway","volume":"403","author":"Zhong","year":"2017","journal-title":"Cancer Lett."},{"key":"ref_98","first-page":"7196","article-title":"Long noncoding RNA GHET1 promotes the development of bladder cancer","volume":"7","author":"Li","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Berrondo, C., Flax, J., Kucherov, V., Siebert, A., Osinski, T., Rosenberg, A., Fucile, C., Richheimer, S., and Beckham, C.J. (2016). Expression of the Long Non-Coding RNA HOTAIR Correlates with Disease Progression in Bladder Cancer and Is Contained in Bladder Cancer Patient Urinary Exosomes. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0147236"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1016\/j.bbamcr.2017.08.001","article-title":"lncRNA H19 regulates epithelial-mesenchymal transition and metastasis of bladder cancer by miR-29b-3p as competing endogenous RNA","volume":"1864","author":"Lv","year":"2017","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1158\/1078-0432.CCR-13-1455","article-title":"TGF-beta-induced upregulation of malat1 promotes bladder cancer metastasis by associating with suz12","volume":"20","author":"Fan","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1159\/000475910","article-title":"LncROR Promotes Bladder Cancer Cell Proliferation, Migration, and Epithelial-Mesenchymal Transition","volume":"41","author":"Chen","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.bbrc.2018.04.010","article-title":"LncRNA TP73-AS1 predicts the prognosis of bladder cancer patients and functions as a suppressor for bladder cancer by EMT pathway","volume":"499","author":"Tuo","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1016\/j.febslet.2015.08.020","article-title":"Double-negative feedback loop between long non-coding RNA TUG1 and miR-145 promotes epithelial to mesenchymal transition and radioresistance in human bladder cancer cells","volume":"589","author":"Tan","year":"2015","journal-title":"FEBS Lett."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/cas.12844","article-title":"Long non-coding RNA urothelial cancer-associated 1 promotes bladder cancer cell migration and invasion by way of the hsa-miR-145-ZEB1\/2-FSCN1 pathway","volume":"107","author":"Xue","year":"2016","journal-title":"Cancer Sci."},{"key":"ref_106","first-page":"5556","article-title":"LncRNA UCA1 promotes the invasion and EMT of bladder cancer cells by regulating the miR-143\/HMGB1 pathway","volume":"14","author":"Luo","year":"2017","journal-title":"Oncol. Lett."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12935-018-0540-0","article-title":"LncRNA XIST\/miR-200c regulates the stemness properties and tumourigenicity of human bladder cancer stem cell-like cells","volume":"18","author":"Xu","year":"2018","journal-title":"Cancer Cell Int."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"11924","DOI":"10.1038\/srep11924","article-title":"TGF\u03b21 secreted by cancer-associated fibroblasts induces epithelial-mesenchymal transition of bladder cancer cells through lncRNA-ZEB2NAT","volume":"5","author":"Zhuang","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/ncb1722","article-title":"The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1","volume":"10","author":"Gregory","year":"2008","journal-title":"Nat. Cell Biol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.cell.2009.07.011","article-title":"Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells","volume":"138","author":"Shimono","year":"2009","journal-title":"Cell"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1677\/ERC-10-0148","article-title":"The miR-200 family controls beta-tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients","volume":"18","author":"Leskela","year":"2011","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/emboj.2010.358","article-title":"Targeting Notch signalling by the conserved miR-8\/200 microRNA family in development and cancer cells","volume":"30","author":"Vallejo","year":"2011","journal-title":"EMBO J."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ygyno.2010.09.022","article-title":"The expression of the miRNA-200 family in endometrial endometrioid carcinoma","volume":"120","author":"Lee","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"6565","DOI":"10.1158\/0008-5472.CAN-14-1218","article-title":"In vivo disruption of an Rb-E2F-Ezh2 signaling loop causes bladder cancer","volume":"74","author":"Santos","year":"2014","journal-title":"Cancer Res."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/bjc.2016.454","article-title":"MicroRNA promoter methylation: A new tool for accurate detection of urothelial carcinoma","volume":"116","author":"Padrao","year":"2017","journal-title":"Br. J. Cancer"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature11993","article-title":"Natural RNA circles function as efficient microRNA sponges","volume":"495","author":"Hansen","year":"2013","journal-title":"Nature"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nrg3722","article-title":"The rise of regulatory RNA","volume":"15","author":"Morris","year":"2014","journal-title":"Nat. Rev. Genet."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/2\/297\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:25:37Z","timestamp":1760185537000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/2\/297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,13]]},"references-count":117,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,1]]}},"alternative-id":["ijms20020297"],"URL":"https:\/\/doi.org\/10.3390\/ijms20020297","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,13]]}}}